SEC filings by BIONTECH SE (ownership)Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|
SC 13D | 2024-02-21 | BioNTech SE | Autolus Therapeutics plc | 33,333,333 | 12.5% | EDGAR |
SC 13G/A | 2024-02-14 | Medine GmbH | BioNTech SE | 40,439,542 | 17.0% | EDGAR |
SC 13G/A | 2024-02-07 | ATHOS KG | BioNTech SE | 104,049,145 | 43.8% | EDGAR |
SC 13G/A | 2023-02-22 | Medine GmbH | BioNTech SE | 41,405,853 | 17.0% | EDGAR |
SC 13G/A | 2023-02-14 | ATHOS KG | BioNTech SE | 105,613,143 | 43.5% | EDGAR |
SC 13G/A | 2022-02-14 | Medine GmbH | BioNTech SE | 41,505,853 | 17.1% | EDGAR |
SC 13G/A | 2022-02-11 | ATHOS KG | BioNTech SE | 106,114,901 | 43.8% | EDGAR |
SC 13G/A | 2021-02-16 | ATHOS KG | BioNTech SE | 114,410,338 | 46.4% | EDGAR |
SC 13G/A | 2021-02-16 | Medine GmbH | BioNTech SE | 41,663,430 | 16.9% | EDGAR |
SC 13G/A | 2021-02-16 | MIG Verwaltungs AG | BioNTech SE | 700,845 | 0.3% | EDGAR |
SC 13G | 2020-02-14 | MIG Verwaltungs AG | BioNTech SE | 13,556,106 | 6.0% | EDGAR |
SC 13G | 2020-02-13 | Medine GmbH | BioNTech SE | 41,690,970 | 18.4% | EDGAR |
SC 13G | 2020-02-12 | ATHOS KG | BioNTech SE | 114,141,520 | 50.3% | EDGAR |
SC 13D | 2020-01-23 | BioNTech SE | Neon Therapeutics, Inc. | 10,407,745 | 36.2% | EDGAR |